Fig. 13
From: Advances in molecular pathology and therapy of non-small cell lung cancer
Flowchart for attaining optimal drug treatment efficacy in NSCLC. This flowchart represents an ideal scenario, and not all drugs or treatments will necessarily follow this development process. The exploration of mechanisms is the most critical and fundamental step. Without this, subsequent steps might merely be illusory. The battle against NSCLC requires close collaboration among various teams, which involves searching for precise internal markers within seemingly random surface events and strategically allocating dominant and cooperative roles in combination therapy to ultimately conquer this formidable disease
